303 related articles for article (PubMed ID: 32878787)
1. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
[TBL] [Abstract][Full Text] [Related]
2. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
Petpiroon N; Sritularak B; Chanvorachote P
BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
[TBL] [Abstract][Full Text] [Related]
3. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811
[TBL] [Abstract][Full Text] [Related]
4. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
[TBL] [Abstract][Full Text] [Related]
5. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
[TBL] [Abstract][Full Text] [Related]
6. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
Nonpanya N; Sanookpan K; Joyjamras K; Wichadakul D; Sritularak B; Chaotham C; Chanvorachote P
PLoS One; 2021; 16(8):e0254929. PubMed ID: 34383763
[TBL] [Abstract][Full Text] [Related]
7. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
Tungsukruthai S; Sritularak B; Chanvorachote P
Anticancer Res; 2017 Nov; 37(11):6311-6319. PubMed ID: 29061814
[TBL] [Abstract][Full Text] [Related]
8. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
Unahabhokha T; Chanvorachote P; Pongrakhananon V
Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
[TBL] [Abstract][Full Text] [Related]
9. Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.
Treesuwan S; Sritularak B; Chanvorachote P; Pongrakhananon V
Sci Rep; 2018 May; 8(1):8009. PubMed ID: 29789636
[TBL] [Abstract][Full Text] [Related]
10. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
[TBL] [Abstract][Full Text] [Related]
11. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
Lee JH; Chinnathambi A; Alharbi SA; Shair OHM; Sethi G; Ahn KS
Pharmacol Res; 2019 Dec; 150():104504. PubMed ID: 31678208
[TBL] [Abstract][Full Text] [Related]
12. COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
Jiang GB; Fang HY; Tao DY; Chen XP; Cao FL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3838-3846. PubMed ID: 31115011
[TBL] [Abstract][Full Text] [Related]
13. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
Putri HE; Sritularak B; Chanvorachote P
Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282
[TBL] [Abstract][Full Text] [Related]
14. Pongamol Inhibits Epithelial to Mesenchymal Transition Through Suppression of FAK/Akt-mTOR Signaling.
Putri HE; Sritularak B; Chanvorachote P
Anticancer Res; 2021 Dec; 41(12):6147-6154. PubMed ID: 34848469
[TBL] [Abstract][Full Text] [Related]
15. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
Luo W; Liu Q; Jiang N; Li M; Shi L
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
[TBL] [Abstract][Full Text] [Related]
16. Structure Identification of ViceninII Extracted from
Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689
[TBL] [Abstract][Full Text] [Related]
17. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
18. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
19. Cycloartocarpin Inhibits Migration through the Suppression of Epithelial-to-Mesenchymal Transition and FAK/AKT Signaling in Non-Small-Cell Lung Cancer Cells.
Tungsukruthai S; Sritularak B; Chanvorachote P
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500213
[TBL] [Abstract][Full Text] [Related]
20. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
